THC to Explore Net Gram Royalties in Medical Marijuana
10 Aprile 2014 - 3:32PM
Marketwired
THC to Explore Net Gram Royalties in Medical Marijuana
TORONTO, ONTARIO--(Marketwired - Apr 10, 2014) - Thelon Capital
Ltd. (the "Company") (TSX-VENTURE:THC)(FRANKFURT:TFHC) is pleased
to announce, as part of its ongoing evaluation of new
opportunities, that it has entered into an arrangement with Net
Gram Royalty Co. ("NGR"), a private consultant, to further explore
and to help negotiate Net Gram Royalty agreements with various
licensed producers. Mr. Scott Walters says "We are excited to work
with NGR to further define the opportunity of supporting the
growing network of licensed producers of marijuana for medically
prescribed use in Canada. We feel the use of a net gram royalty
model fits the needs of this industry by supporting the growers
whose work benefits specific needs of patients."
About Net Gram Royalty Co. ("NGR")
NGR provides non-equity funding to licensed producers ("LPs") of
medical marijuana. Its goal is to provide diversified risk
mitigated exposure to the medical marijuana market for investors,
and a robust supply of medical marijuana for patients. NGR will
meet this rapidly growing demand for funding in the medical
marijuana production sector using a commodity streaming model,
rather than a direct equity investment. Thus NGR mitigates early
stage venture risks.
NGR is in the process of due diligence with several producers to
fund dried marijuana royalty agreements in its first twelve months
of operation. NGR's business model is highly scalable, and will
efficiently serve the needs of medical marijuana patients, LPs, and
investors within the parameters of a rapidly expanding market.
NGR's Net Gram Return royalty model is analogous to the method
used by successful mineral commodities streaming companies such as
Sandstorm Gold (SSL), Silver Wheaton Corp (SLW), Franco Nevada
(FNV) and others.
Net Gram Return royalties are based on the value of production
or net proceeds received from the legal sale of medical marijuana
by a Licensed Producer (LP) from an indoor growing operation under
Canada's Federal "Marijuana for Medical Purposes Regulations".
These sales are made direct to registered patients from the LP.
This type of marijuana royalty potentially provides for significant
and tax advantaged cash flow that is free of any operating or
capital costs and environmental liabilities and allows for capital
risk reduction in gaining exposure to a developing marketplace.
The Company continues to evaluate new projects, including, but
not limited to, opportunities in agriculture, finance, and
resources. At this time, no transactions are in place, nor is there
any assurance that a new project will be concluded in the
future.
ON BEHALF OF THE BOARD OF DIRECTORS
Scott Walters, President & Chief Executive Officer
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy of
accuracy of this release.
This news release contains forward-looking statements that
involve risks and uncertainties. Forward-looking statements or
information are based on current expectations, estimates and
projections that involve a number of risks and uncertainties which
could cause actual results to differ materially from those
anticipated by the Company. The forward-looking statements or
information contained in this news release are made as of the date
hereof and the Company does not undertake any obligation to update
publicly or revise any forward-looking statements or information,
whether as a result of new information, future events or otherwise,
unless so required by applicable securities laws.
Thelon Capital Ltd.(604) 682-1643(604)
682-1666www.theloncapital.com
Grafico Azioni Thelon Capital Ltd. (TSXV:THC)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Thelon Capital Ltd. (TSXV:THC)
Storico
Da Nov 2023 a Nov 2024